Company: ICUI
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0000883984-25-000007
Chunk: 194

Company: ICU MEDICAL INC/DE
Filing Date: 2025-02-27
Form: 10-K
Item: Item 1
Chunk 194
---
66,745 100,497 DEFERRED INCOME TAXES48,814 55,873 INCOME TAX LIABILITY35,097 35,060 COMMITMENTS AND CONTINGENCIES (Note 16)— — STOCKHOLDERS’ EQUITY:  Convertible preferred stock, $1.00 par value; Authorized—500 shares; Issued and outstanding— none— — Common stock, $0.10 par value; Authorized—80,000 shares; Issued—24,518 and 24,144 shares at December 31, 2024 and 2023, respectively, and outstanding—24,517 and 24,141 shares at December 31, 2024 and 2023, respectively2,452 2,414 Additional paid-in capital1,412,118 1,366,493 Treasury stock, at cost (571 and 2,428 shares, respectively)(92)(262)Retained earnings690,158 807,846 Accumulated other comprehensive loss(139,401)(53,081)TOTAL STOCKHOLDERS' EQUITY1,965,235 2,123,410 TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY$4,203,931 $4,378,439 

The accompanying notes are an integral part of these consolidated financial statements.

62

ICU MEDICAL, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

(Amounts in thousands, except per share data)

 Year ended December 31, 202420232022TOTAL REVENUES$2,382,046 $2,259,126 $2,279,997 COST OF GOODS SOLD1,557,264 1,519,253 1,582,236 GROSS PROFIT824,782 739,873 697,761 OPERATING EXPENSES:  Selling, general and administrative638,762 606,693 608,345 Research and development88,615 85,344 92,984 Restructuring, strategic transaction and integration59,840 41,258 71,421 Change in fair value of contingent earn-out(5,399)(16,247)(32,091)TOTAL OPERATING EXPENSES781,818 717,048 740,659 INCOME (LOSS) FROM OPERATIONS